dementia glp-1 What's Next for Alzheimer's Treatment? Some Scientists Are Betting on Drugs GLP-1 and the Degenerating Brain:

Source: Bravo, Laura, Sara MartnezLpez, Jose Luis SierraCinos, Raquel Mateos, and Beatriz Sarri

People with severe kidney or liver disease may require caution or alternative treatments, and their use should be discussed with healthcare providers

Compounded Tirzepatide: A novel dual GIP and GLP-1 receptor agonist, offering even greater efficacy for weight loss, compounded by FDA-registered and inspected pharmacies

It looks pretty, it looks nice, but its cement

The 17.2 mg tablet delivers the same dose as the 36 mg capsule used in the trial and produces an average weight loss of 11.1% at the approved dose, essentially matching the trial result